El secado por aspersión es una técnica de amplio uso en la industria de alimentos para la obtención de productos en polvo a partir de la formación de gotas pequeñas dentro de una cámara de secado a temperatura elevada. Esta técnica de secado se ha aplicado a la formación de microcápsulas que albergan compuestos funcionales con el objetivo de suplementar un alimento mediante la adición de uno o varios ingredientes esenciales que pueden proporcionar beneficios para la salud humana. En esta revisión, se recopiló información sobre el proceso de microencapsulación de secado por aspersión: el principio y las condiciones de operación, los materiales pared utilizados, su influencia sobre las propiedades fisicoquímicas y funcionales de las microcápsulas obtenidas, los problemas de calidad en las microcápsulas, los aspectos de liberación de los compuestos bioactivos y los estudios relacionados con la microencapsulación de vitaminas, minerales, sustancias oleosas, antioxidantes y microorganismos probióticos. En total, se consultaron 78 estudios publicados entre los años 2010 y 2020 en bases de datos de alto impacto en la comunidad científica. Se observó que algunas combinaciones de compuestos bioactivos, con propiedades fisicoquímicas y funcionales definidas, dan origen a nuevos alimentos funcionales que mejoran en alto grado la salud de quienes los consumen con frecuencia. Los adelantos en el área de la microencapsulación mediante secado por aspersión son numerosos y coinciden con las nuevas tendencias de desarrollo e innovación en el ámbito alimentario.
Previous studies indicate that the alkali-induced oxidation of quercetin (Que) or kaempferol (Kae) converts them into hydroxylated-benzoyl-benzofuranones (BZFs), a type of metabolite whose antioxidant potency is substantially higher. To explore whether the former conversion can take place under a more biologically relevant oxidizing setting, these flavonols were incubated in a nitrite-containing acidic medium. Under such condition, the concentrations of Que or Kae rapidly decayed, simultaneously generating their corresponding BZFs. When Que and Kae were co-incubated, the depletion of the parent flavonols accelerated without changes in BZF formation. Similar results were observed when either Que or Kae were incubated with some of their corresponding 3-O-glycosides. In turn, when Que was co-incubated with certain flavanols or phenolic acids, the latter compounds nearly doubled not only the oxidative disappearance of Que but also its BZF formation. Interestingly, the concentrations of Que-BZF and Kae-BZF reached under all former incubation scenarios are greater than those previously reported to be needed to protect intestinal epithelial cells against the oxidative and lytic damage induced by ROS. We suggest that, if these conversions also took place in vivo, the gastric fluid could be potentially seen as a chemical milieu where the antioxidant properties of Que and Kae could be enormously amplified.
Greywater reuse has emerged as a promising strategy to reduce pressure on freshwater resources, but little is known about the impact that emerging contaminants may have on its safe application. This study evaluated the performance of hollow fiber membrane bioreactors (HFMBs) for synthetic greywater treatment under control conditions and exposure to two widely used pharmaceutical compounds: ibuprofen and diclofenac. Nine HFMBs were operated for 11 days using synthetic greywater without pharmaceuticals (control), ibuprofen-amended greywater, or diclofenac-amended greywater. Reactor performance was assessed through physicochemical parameters and microbial community analysis. Turbidity and soluble chemical oxygen demand (sCOD) decreased in all reactors and were adequately described by an empirical temporal stabilization model. Turbidity removal was comparable among treatments, whereas final sCOD removal differed among reactor conditions. Anionic surfactants were markedly reduced, with removal efficiencies above 98% in all systems. In contrast, ibuprofen and diclofenac showed small and variable decrease in measured concentrations, but no statistically significant differences were detected between initial and final concentrations. Microbial community analysis revealed that Pseudomonadota was the dominant phylum in the HFMB reactors. Functional prediction further indicated an enrichment of pathways associated with aromatic compound degradation and biofilm-related processes across the reactor configuration and operating conditions. Moreover, the diclofenac treatment exhibited an additional enrichment of functions related to environmental stress resistance and an enhanced potential for aromatic compound degradation compared with the control treatment.
Exposure of quercetin (Que) or kaempferol (Kae) to a nitrous-acid containing pseudo-gastric fluid (PGF) leads to their oxidative conversion into their respective hydroxylated-benzoyl-benzofuranones (BZFs), Que-BZF and Kae-BZF. This study evaluated the implications that the referred conversion could have on the antioxidant properties, cellular metabolic activity, and membrane integrity of such fluids when added to Caco-2 cells exposed to the ROS-generator, indomethacin. The addition of PGF containing either Que-BZF or Kae-BZF to the cells concentration-dependently (10–100 nM) prevented indomethacin-induced oxidative stress (dichlorodihydrofluorescein oxidation), mitochondrial-dependent metabolic dysfunction (MTT reduction), and plasma membrane disruption (LDH leakage). To achieve a level of intracellular antioxidant protection (80%), metabolic preservation (100%), and membrane integrity protection (100%) comparable to that induced by 10 nM of Que-BZF or Kae-BZF in the PGF, concentrations of quercetin or kaempferol of 10 µM, that is, three-orders of magnitude higher, were required. At 100 nM, the BZFs contained in the PGF promoted Nrf2 nuclear translocation and induced a near five-fold increase in the levels of the antioxidant enzymes HO-1 and NQO1, regardless of indomethacin treatment. Therefore, the present in vitro chemical simulation and cellular model of intestinal epithelium study demonstrates that the oxidative conversion that quercetin and kaempferol undergo following their incubation in a nitrous acid-containing PGF results in a substantial amplification of their original antioxidant and cytoprotective capabilities and suggests that the latter effects arise from the extremely potent ability of the hydroxylated-benzoyl-benzofuranones to activate the Nrf2-Keap1 pathway.